95013 ⎘
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS
#2THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF
#3PROCESS FOR C-H INSERTION BY GEM-HYDROGENATION OF AN INTERNAL ALKYNE
#4GRISEOFULVIN COMPOUND
#5MODULATORS OF KV3 CHANNELS TO TREAT PAIN
#6RADIATION-SENSITIVE COMPOSITION, PATTERN FORMATION METHOD, AND PHOTO-DEGRADABLE BASE
#7ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#8NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE
#9METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS
#10N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#11PHOTOCHEMICAL PREPARATION OF FLUORINE-CONTAINING COMPOUNDS
#12GRISEOFULVIN 4 POSITION ETHERIFIED DERIVATIVES AND THEIR APPLICATION
#13GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF
#14Griseofulvin compound
#15COMPOUNDS FOR ELECTRONIC DEVICES
#16METHOD FOR PREPARING CHIRAL MALEIMIDE DERIVATIVES USING ORGANIC CHIRAL CATALYST COMPOUNDS AND ECO-FRIENDLY SOLVENTS
#17Methods and compositions for terpenoid synthesis
#18AGAROFURAN COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#19CYCLIC CYANOENONE DERIVATIVES AS MODULATORS OF KEAP1
#20NOVEL COMPOUND USEFUL AS TOLL-LIKE RECEPTOR 7 ACTIVATION INHIBITOR
#21ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME
#22LIPIDS FOR DELIVERY OF NUCLEIC ACID SEGMENTS
#23Griseofulvin compound
#24HETEROCYCLIC SPIRO COMPOUNDS
#25Griseofulvin compound and pharmaceutical use thereof
#265-hydroxytryptamine receptor 7 activity modulators and their method of use
#27SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE
#28Modulators of Kv3 channels to treat pain
#29Hydantoin derivatives useful as Kv3 inhibitors
#30TRICYCLIC SPIRO COMPOUND
#31SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS
#32Griseofulvin compound
#33Methods of use of cyclopamine analogs
#34Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#35Liphagal analog and multi-targeted kinase inhibitor containing liphagal or analog thereof
#36ORGANIC LIGHT EMITTING DIODE FOR HIGH EFFICIENCY
#37SPIROCYCLIC COMPOUNDS AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
#38Compounds
#39Hydantoin derivatives useful as Kv3 inhibitors
#405-hydroxytryptamine receptor 7 activity modulators and their method of use
#41Heterocyclic spiro compounds
#42Griseofulvin compound
#435-hydroxytryptamine receptor 7 activity modulators and their method of use
#44Griseofulvin compound and pharmaceutical use thereof
#45Compounds
#46Triazoles as Kv3 inhibitors
#47DIANHYDRIDES, POLYIMIDES DERIVED FROM BISCATECOL, METHODS OF MAKING, AND METHODS OF USE
#48Organic light emitting diode having high efficiency
#49Cyclopamine analogs
#50Tricyclic spiro compound
#51Highly diastereoselective construction of the 4,5-spirocycle via palladium-catalyzed intramolecular alkenylation
#52Methods of use of cyclopamine analogs
#53Griseofulvin compound
#545-hydroxytryptamine receptor 7 activity modulators and their method of use
#55Heteroaromatic compound and organic electroluminescence device using the same
#56Methods and compositions for terpenoid synthesis
#57HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
#58Compounds
#59Griseofulvin compound
#60Triazoles as Kv3 inhibitors
#61Compounds
#62Modulators of KV3 channels to treat pain
#63Cyclopamine analogs
#64Dianhydrides, polyimides derived from biscatecol, methods of making, and methods of use
#65Organic light-emitting compound and organic light-emitting diode comprising same
#66Methods of use of cyclopamine analogs
#67Tricyclic spiro compound
#68Ion-activated photolabile compounds
#69Materials for electronic devices
#70Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#71Spiro-type compound and organic light emitting diode comprising same
#72Miliusanes as antiviral agents
#73Compound and organic electronic device using the same
#74Spiro compound and organic electronic device comprising the same
#75Compounds
#76Organic electroluminescent device
#77Spirobifluorene derivative-based materials for electronic devices
#785-hydroxytryptamine receptor 7 activity modulators and their method of use
#795-hydroxytryptamine receptor 7 activity modulators and their method of use
#80Organic light-emitting diode having low driving voltage and long lifespan
#81Anthracene derivatives for organic light-emitting diode and organic light-emitting diode including the same
#82Tricyclic spiro compound
#83Methods of use of cyclopamine analogs
#84Organic compound and light emitting diode and organic light emitting diode display device using the same
#85Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#86Materials for electronic devices
#875-hydroxytryptamine receptor 7 activity modulators and their method of use
#88Hydantoin derivatives useful as Kv3 inhibitors
#89INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES
#90Organic electroluminescent device
#91Resist composition, pattern forming process, polymer, and monomer
#92Form of spirodiclofen, a process for its preparation and use the same
#93Organic light-emitting diode with high efficiency
#94Organic light-emitting diode with high efficiency and low voltage
#95Acid diffusion control agent, radiation-sensitive resin composition, resist pattern-forming method, compound, and production method
#96C-glycoside derivative
#97Condensed cyclic compound and organic light-emitting device including the same
#98Cyclopamine analogs
#99Organic light emitting diode for high efficiency
#100Photoresist composition, compound, and production method thereof
#101Triazoles as KV3 inhibitors
#102Compounds
#103Heterocyclic spiro compounds
#104GRISEOFULVIN DERIVATIVES
#105HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
#106Materials for electronic devices
#107Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#108Methods of use of cyclopamine analogs
#109Organic compound and organic light emitting diode device including the same
#110Carbofluorescein lactone ion indicators and their applications
#111Anticancer miliusane derivatives
#1125-hydroxytryptamine receptor 7 activity modulators and their method of use
#113Anticancer compounds and process for the preparation thereof
#114Compounds
#115Organic light emitting compound and organic light emitting device including the same
#116Monomer, polymer, resist composition, and patterning process
#117Ingenol-3-acylates III and ingenol-3-carbamates
#118Antitumor Agent
#119Griseofulvin derivatives
#120Griseofulvin derivatives
#121Hydantoin derivatives as Kv3 inhibitors
#122Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#123Triazoles as Kv3 inhibitors
#124Acid diffusion control agent, radiation-sensitive resin composition, resist pattern-forming method, compound, and production method
#125Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#126Compounds for organic electronic devices
#127Photoresist composition, compound, and production method thereof
#128Carbofluorescein lactone ion indicators and their applications
#129Cyclopamine analogs
#1303,3-diethyl-alkyl-2-oxa-spiro[4.5]dec-7-enes and their use in perfume compositions
#131Compounds
#132Ingenol-3-acylates III and ingenol-3-carbamates
#133Compounds for electronic devices
#134Haloalkylmethyleneoxyphenyl-substituted ketoenols
#135Tricyclic compounds as anticancer agents
#136C-9 oxygen functionalized labdane derivates
#137POLYCYCLIC COMPOUNDS AND METHODS RELATED THERETO
#138C-glycoside derivatives
#139GPR120 RECEPTOR AGONISTS AND USES THEREOF
#140Hydantoin derivatives as KV3 inhibitors
#141Fluorescent probes for detection of copper
#142Haloalkylmethyleneoxyphenyl-substituted ketoenols
#143Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom
#144Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct
#145Anti-cancer agents synthesized based on miliusane compounds
#146Hydantoin derivatives useful as Kv3 inhibitors
#147Methods for the preparation of drospirenone and intermediates thereof
#148Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#149C2-phenyl-substituted cyclic ketonols
#150ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS
#151CYCLIC KETOENOLS FOR THERAPY
#152ANTI-VIRAL COMPOUNDS, COMPOSITIONS AND METHODS
#153Methods of use of cyclopamine analogs
#154ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS
#155Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
#156CARBOXYLIC ACID COMPOUND
#157Resist composition, method of forming resist pattern, compound and acid generator
#158GPR120 receptor agonists and uses thereof
#159Biphenyl-substituted spirocyclic ketoenols
#160Novel Polyisoprenylated Benzophenone Derivatives from Garcinia paucinervis
#161Polycyclic compounds and methods related thereto
#162Cyclopentadione derived herbicides
#163Oxaspirocyclic spiro-substituted tetramic acid and tetronic acid derivatives
#164METHODS OF USE FOR CYCLOPAMINE ANALOGS
#1652,4,6-Phenyl-Substituted Derivatives
#1662,4,6-Phenyl-Substituted Cyclic Ketoenols
#167C-phenyl-substituted cyclic ketonols
#168Methods for obtaining cyclopamine
#169C-phenyl-substituted cyclic ketonols
#1702,4,6-Phenyl-substituted cyclic ketoenols
#171Materials for organic electroluminescence device
#172Platensimycin derivatives, their intermediates, and process for preparing the same, and new process for preparing platensimycin
#173Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof
#174Salt and photoresist composition containing the same
#175Haloalkylmethyleneoxyphenyl-substituted ketoenols
#176Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#177Methods of use of cyclopamine analogs
#178Hydrogenation of esters with Ru/bidentate ligands complexes
#179Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives
#180GPR120 receptor agonists and uses thereof
#181Spirocyclic tetronic acid derivatives
#182Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
#183Resist composition, method of forming resist pattern, novel compound, and acid generator
#184SUBSTITUTED AMINOFURANONES AND THEIR USE
#185Compound, acid generator, resist composition, and method of forming resist pattern
#186Arylphenyl-substituted cyclic keto-enols
#187Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
#188Inhibitors of papilloma virus
#189BIPHENYL SUBSTITUTED SPIROTETRONIC ACIDS AND THEIR USE FOR THE TREATMENT OF RETROVIRAL DISEASES
#190Resist composition, method of forming resist pattern, compound and acid generator
#191Iodine-phenyl-substituted cyclic cetoenols
#1923′-alkoxyspirocyclopentyl-substituted tetramic and tetronic acids
#193Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action
#194PARA-QUINOL DERIVATIVES AND METHODS OF STEREO SELECTIVELY SYNTHESIZING AND USING SAME
#1953,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE DERIVATIVES AS POTASSIUM CHANNEL OPENERS
#196Process for producing optically active theaspirane
#197Luminescence quenchers and fluorogenic probes for detection of reactive species
#198Substituted cycloalkene derivative
#199Cyclopamine analogs
#2001-oxaspiro (4, 5) dec-3-ene derivatives as perfuming ingredients
#201Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
#202Process For Preparing [2-(2,3- Dihydrobenzofuran - Or Benzofuran-7-Yloxy)Ethyl]-(3 -Cyclopent-1-Ylbenzyl)Amine Derivatives and Synthesis Intermediate
#203Spirocyclic 3'-alkoxytetramic acids and-tetronic acids
#204Cyclopamine analogs
#205Cyclopamine analogs
#206Spirocyclic 3-phenyl-3substituted-4-ketolactams and-lactones
#207Materials for organic electroluminescent devices
#208Flourene Derivative
#209Medicament For Irritable Bowel Syndrome
#210Carbamoyl-substituted spiro derivative
#211Arylphenyl-substituted cyclic keto-enols
#2122,4,6-phenyl-substituted cyclic ketoenols
#2133,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
#214Novel Tricyclic Spiroderivatives as Modulators of Chemokine Receptor Activity
#215Novel Tricyclic Spiroderivatives as Modulators of Chemokine Receptor Activity
#216Cyclic amine derivative or salt thereof
#217Fungicides compositions comprising the extract of and a novel sesquiterpene compound isolated from them
#218Nonsteroidal progesterone receptor modulators
#219HIV protease inhibitors
#220Derivatives and analogs of galanthamine
#221Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
#2222,4,6-phenyl substituted cyclic ketoenols
#2233-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
#224Inhibitors of papilloma virus
#225Unsaturated carboxylic acid hemicacetal ester, polymeric compound and photoresist resin composition
#226Arylphenyl-substituted cyclic ketoenols
#227Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolylcis/trans-isomerases
#2283-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
#229Herbicides
#230Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
#231Herbicides
#232Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
#233Method of substituent introduction through halogen-metal exchange reaction
#234Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
#235Spiro compounds
#236Inhibitors of papilloma virus
#237Fluorogenic calcium ion indicators and methods of using the same